ah
mH
Q 08
o
oo
Pop. ave. dose (cSv)
1
2
{
2
oO
>
¢ ost
®
2 0.4}
0.4
&
z 0.2
E
0.2
°
=
5
1
86
20
283
°
0
0.2
0.4
0.6
Population average 30-y
Cumulative exposure time (y)
0.8
1
(cSv)
Figure 21. Population-average expected dose
from hypothetical residence on Rongelap Island
starting in 1995 (middle curve) and corresponding
two-tail 95% confidence limits on uncertainty in
population-average dose, as a function of
residence time.
2
w®&
SS
®
Cumulative probability
10
18
20
2
30
Cumulative exposure time (y)
Figure 22. Two-tail 95% confidence limits on
“uncertainty in population-average dose from
hypothetical residence on Rongelap Island
starting in 1995 as ratios of the corresponding
expected value of this dose (horizontal line) at specified residence times.
o
ao
5
ho
sos
~~
in
Dose/(Expected dose)
~—h
cSv and 50th, 95th and 99th perce
0.56, 0.84 and 1.0 cSv, respectively.
025 05 0.75
1
#125 15
Population average lifetime dibse
1.75
2
(cSv)
Figure 24. Estimated distribution uncertainty
in population-average lifejime dose
corresponding to hypothetical resifience of 500
people on Rongelap Island s
g in 1995,
assuming 40% incur a 70-y exposure {i.e.,
commencing at birth) and 60%
exposure. This distribution has a
incur a 30-y
and 50th
and 95th percentile values of 0.45,0.36 and 1.0
cSv, respectively.